Literature DB >> 624854

Topical treatment of vaccinia virus infection with an interferon inducer in rabbits.

H B Levy, E Lvovsky.   

Abstract

Ointment containing 1.7 mg/g of the interferon inducer poly (ICLC) (a complex of polyriboinosinic-polyribocytidylic acid and with poly-L-lysine and carboxymethylcellulose) was effective both prophylactically and therapeutically against vaccinia virus infection in rabbit skin. Poly (ICLC)-treated animals developed higher titers of local interferon and of circulating virus-neutralizing antibodies than placebo-treated animals. Serum levels of greater than 100 units of interferon/ml were found 24 hr after application of the poly (ICLC) ointment to the skin of uninfected rabbits.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 624854     DOI: 10.1093/infdis/137.1.78

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  4 in total

Review 1.  The interferon renaissance: molecular aspects of induction and action.

Authors:  J Gordon; M A Minks
Journal:  Microbiol Rev       Date:  1981-06

2.  Topical polyriboinosinic-polyribocytidylic acid complex in the treatment of recurrent genital herpes.

Authors:  L R Crane; H B Levy; A M Lerner
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

3.  Trial Watch: Experimental Toll-like receptor agonists for cancer therapy.

Authors:  Lorenzo Galluzzi; Erika Vacchelli; Alexander Eggermont; Wolf Hervé Fridman; Jerome Galon; Catherine Sautès-Fridman; Eric Tartour; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2012-08-01       Impact factor: 8.110

4.  TLR3 and TLR9 agonists improve postexposure vaccination efficacy of live smallpox vaccines.

Authors:  Tomer Israely; Sharon Melamed; Hagit Achdout; Noam Erez; Boaz Politi; Trevor Waner; Shlomo Lustig; Nir Paran
Journal:  PLoS One       Date:  2014-10-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.